Vanina Taliercio

Vanina Taliercio

Auto-generated profile, based on publicly available information

Vanina Taliercio

Department of Pediatrics, Division of Medical Genetics University of Utah Salt Lake City Utah USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in International Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
ASAshley M. Snyder
Ashley M. Snyder
ABAdelheid U. Brandenberger
Adelheid U. Brandenberger
VTVanina L. Taliercio
Vanina L. Taliercio
BRBianca E. Rich
Bianca E. Rich
LWLisa B. Webber
Lisa B. Webber
ASAaron M. Secrest
Aaron M. Secrest

4 October 2021 in JMIR Dermatology
Verified
Journal Article
Open access
ASAshley M Snyder
Ashley M Snyder
VTVanina L Taliercio
Vanina L Taliercio
ABAdelheid U Brandenberger
Adelheid U Brandenberger
BRBianca E Rich
Bianca E Rich
LWLisa B Webber
Lisa B Webber
ASAaron M Secrest
Aaron M Secrest
Background: Pain is an underappreciated symptom of atopic dermatitis that can affect the health-related quality of life (HRQL) of patients. Objective: The aim of this study is to understand the effect of pain on patients with atopic dermatitis and their family members and to recognize how this symptom affects HRQL. Methods: We conducted focus groups and interviews with patients with atopic dermatitis and their family members. Researchers independently coded the transcripts and reached a consensus on the major themes. Results: A total of 33 adult participants, consisting of 21 patients with atopic dermatitis (median age 47 years, range 22-77) and 12 family members (median age 50, range 22-72), attended either focus groups (23/33, 70%) or interviews (10/33, 30%), where we assessed their experiences of pain. Four themes emerged in our study. Itchiness and pain can be intertwined: pain was often caused by or otherwise associated with itchiness and could result from open sores and excoriated skin. Characteristics of pain: pain was most often described as burning. Other descriptors included mild, persistent discomfort; stinging; and stabbing. Effects of pain: pain negatively affected various aspects of daily life, including choice of clothing, sleep, social activities, and relationships. The location of painful areas could also limit physical activity, including sex. Pain management: pain from atopic dermatitis could be managed to varying degrees with different over-the-counter and prescription treatments. Systemic agents that cleared the skin also resolved the pain associated with atopic dermatitis. Conclusions: Pain can be a significant factor in the HRQL of patients with atopic dermatitis and should be considered by clinicians when caring for patients with atopic dermatitis.

3 May 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
VTV. Taliercio
V. Taliercio
JZJ. Zhao
J. Zhao
SBS. E. Boyden
S. E. Boyden
RMR. Mao
R. Mao
PBP. Bayrak‐Toydemir
P. Bayrak‐Toydemir
DVD. Viskochil
D. Viskochil
Gorlin‐Goltz Syndrome (GGS) is a rare autosomal dominant genetic disorder encompassing a diverse range of clinical manifestations, including congenital anomalies and predisposition to cancer. Pathogenic variants in PTCH1 and SUFU account for up to 79% and 6% of cases, respectively. Currently, an estimated 15%–27% of individuals with a clinical diagnosis of GGS do not have a pathogenic variant identified in either gene. We report on a 17‐year‐old female referred to the Undiagnosed Disease Network with a clinical diagnosis of GGS that manifested as both classic and unusual findings, including isolated hypogonadotropic hypogonadism and anosmia (Kallmann syndrome), orofacial cleft, and abnormal semicircular canals (SCC). Prior genetic testing, including a targeted gene panel, genomic microarray, exome sequencing, and genome sequencing, was non‐diagnostic, although these studies identified a variant of uncertain significance in CHD7, which may have contributed to elements of the phenotype (e.g., abnormal SCC). Reanalysis of genome sequencing data using research analytic methods, together with karyotyping, FISH, and Sanger sequencing, identified a novel de novo paracentric inversion that truncated PTCH1. These findings underscore the value of in‐depth phenotype‐guided genomic analysis, including chromosomal structural variants, as well as the occurrence of possible dual genetic diagnoses in the same individuals. Moreover, the definitive diagnosis provided the patient and family with a firmer basis for management and counseling.

1 February 2026 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
EBElizabeth K. Baker
Elizabeth K. Baker
PSPavalan Selvam
Pavalan Selvam
RMRyan Monsberger
Ryan Monsberger
LPLaura S. Peterson
Laura S. Peterson
JEJohn Erickson
John Erickson
KWK. Nicole Weaver
K. Nicole Weaver

22 April 2021 in JMIR Preprints
Verified
Preprint
Open access
ASAshley M Snyder
Ashley M Snyder
VTVanina L Taliercio
Vanina L Taliercio
ABAdelheid U Brandenberger
Adelheid U Brandenberger
BRBianca E Rich
Bianca E Rich
LWLisa B Webber
Lisa B Webber
ASAaron M Secrest
Aaron M Secrest
BACKGROUND Pain is an underappreciated symptom of atopic dermatitis that can affect the health-related quality of life (HRQL) of patients. OBJECTIVE The aim of this study is to understand the effect of pain on patients with atopic dermatitis and their family members and to recognize how this symptom affects HRQL. METHODS We conducted focus groups and interviews with patients with atopic dermatitis and their family members. Researchers independently coded the transcripts and reached a consensus on the major themes. RESULTS A total of 33 adult participants, consisting of 21 patients with atopic dermatitis (median age 47 years, range 22-77) and 12 family members (median age 50, range 22-72), attended either focus groups (23/33, 70%) or interviews (10/33, 30%), where we assessed their experiences of pain. Four themes emerged in our study. Itchiness and pain can be intertwined: pain was often caused by or otherwise associated with itchiness and could result from open sores and excoriated skin. Characteristics of pain: pain was most often described as burning. Other descriptors included mild, persistent discomfort; stinging; and stabbing. Effects of pain: pain negatively affected various aspects of daily life, including choice of clothing, sleep, social activities, and relationships. The location of painful areas could also limit physical activity, including sex. Pain management: pain from atopic dermatitis could be managed to varying degrees with different over-the-counter and prescription treatments. Systemic agents that cleared the skin also resolved the pain associated with atopic dermatitis. CONCLUSIONS Pain can be a significant factor in the HRQL of patients with atopic dermatitis and should be considered by clinicians when caring for patients with atopic dermatitis.

27 April 2026 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
VTVanina Taliercio
Vanina Taliercio
AWAnnabelle Wilcox
Annabelle Wilcox
SCStacey Cole
Stacey Cole
JDJosue Flores Daboub
Josue Flores Daboub
JMJosé E. Morales Moreno
José E. Morales Moreno
BHBenjamin Hammond
Benjamin Hammond
Arrhythmias affect approximately half of patients with Costello syndrome (CS, OMIM # 218040), with non‐reentrant atrial tachycardia being the most common. This case describes an infant with Costello syndrome carrying the pathogenic HRAS c.34G>A (p.G12S) variant who developed early‐onset, drug‐refractory multifocal atrial tachycardia (MAT). Despite multiple antiarrhythmic therapies, rhythm control remained inadequate until trametinib was initiated, resulting in rapid resolution of MAT and allowing stepwise discontinuation of adjunct antiarrhythmics. Although MAT did not recur after the MEK inhibitor was stopped, the patient subsequently developed hypertrophic cardiomyopathy only after trametinib was discontinued, suggesting a potential disease‐modifying cardioprotective effect during active treatment. This case supports MEK inhibition as a targeted antiarrhythmic strategy in Costello syndrome, with benefits that may extend beyond acute rhythm stabilization to include prevention of cardiac hypertrophy. While spontaneous resolution of MAT can occur in Costello syndrome, the rapid and sustained response in this patient strengthens the hypothesis that trametinib exerts a direct antiarrhythmic effect.